
Chinese General Practice ›› 2027, Vol. 30 ›› Issue (01): 83-90.DOI: 10.12114/j.issn.1007-9572.2026.0223
• Article • Previous Articles
Received:2026-03-18
Revised:2026-08-27
Published:2027-01-05
Online:2026-11-17
Contact:
ZHU Yanbo
通讯作者:
朱燕波
作者简介:作者贡献:
朱燕波与郭艳青负责研究概念设计与论文总体构思;谢陈璐、朱燕波、郭艳青、崔燕共同完成研究可行性分析;郭艳青、崔燕、金丽、郝薇负责数据收集与整理;谢陈璐、朱燕波、任家驹、向瑶月、张艳菊承担数据统计分析;崔燕、郭艳青、朱燕波负责研究过程的质量控制与技术指导;谢陈璐、朱燕波起草论文初稿;谢陈璐、郭艳青、朱燕波、崔燕、金丽、郝薇、任家驹、向瑶月、张艳菊共同参与论文修改与完善;朱燕波对论文整体负责。
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2026.0223
| 模型 | AIC | BIC | aBIC | Entropy | LMRT(P值) | BLRT(P值) | 类别概率 |
|---|---|---|---|---|---|---|---|
| 1 | 60 186.99 | 60 281.11 | 60 230.27 | 1.00 | |||
| 2 | 58 072.27 | 58 219.33 | 58 139.90 | 0.74 | 0.003 3 | 0.002 9 | 0.64/0.36 |
| 3 | 56 198.39 | 56 398.39 | 56 290.36 | 0.82 | 0.004 6 | 0.004 3 | 0.62/0.36/0.03 |
| 4 | 55 358.35 | 55 611.29 | 55 474.67 | 0.78 | 0.032 1 | 0.030 7 | 0.52/0.25/0.20/0.03 |
| 5 | 54 244.34 | 54 550.22 | 54 385.00 | 0.81 | 0.153 5 | 0.151 4 | 0.49/0.24/0.23/0.02/0.01 |
Table 1 Fitting metrics of the potential cardiovascular metabolic risk profile model
| 模型 | AIC | BIC | aBIC | Entropy | LMRT(P值) | BLRT(P值) | 类别概率 |
|---|---|---|---|---|---|---|---|
| 1 | 60 186.99 | 60 281.11 | 60 230.27 | 1.00 | |||
| 2 | 58 072.27 | 58 219.33 | 58 139.90 | 0.74 | 0.003 3 | 0.002 9 | 0.64/0.36 |
| 3 | 56 198.39 | 56 398.39 | 56 290.36 | 0.82 | 0.004 6 | 0.004 3 | 0.62/0.36/0.03 |
| 4 | 55 358.35 | 55 611.29 | 55 474.67 | 0.78 | 0.032 1 | 0.030 7 | 0.52/0.25/0.20/0.03 |
| 5 | 54 244.34 | 54 550.22 | 54 385.00 | 0.81 | 0.153 5 | 0.151 4 | 0.49/0.24/0.23/0.02/0.01 |
| 组别 | 人数 | 性别[名(%)] | 年龄[名(%)] | 吸烟情况[名(%)] | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 男 | 女 | 20~<40岁 | 40~<60岁 | 60~<80岁 | 80~94岁 | 经常吸烟 | 偶尔吸烟 | 已戒烟 | 从不吸烟 | ||
| 健康组 | 1 380 | 843(61.1) | 537(38.9) | 921(66.7) | 304(22.1) | 115(8.3) | 40(2.9) | 189(13.7) | 18(1.3) | 5(0.3) | 1 168(84.6) |
| 血脂异常组 | 655 | 478(73.0) | 177(27.0) | 347(53.0) | 202(30.8) | 78(11.9) | 28(4.3) | 118(18.0) | 8(1.2) | 3(0.5) | 526(80.3) |
| 高血压伴高尿酸组 | 543 | 460(84.7) | 83(15.3) | 277(51.0) | 170(31.3) | 74(13.6) | 22(4.0) | 133(24.5) | 15(2.8) | 12(2.2) | 383(70.5) |
| 高血糖伴高甘油三酯组 | 72 | 55(76.4) | 17(23.6) | 17(23.6) | 26(36.1) | 23(32.0) | 6(8.3) | 22(30.6) | 0 | 0 | 50(69.4) |
| χ2(H)值 | 110.23 | 110.74 | 200.99 | ||||||||
| P值 | <0.001 | <0.001 | <0.001 | ||||||||
| 组别 | 饮酒情况[名(%)] | WH R [M(P25,P75)] | DSI [M(P25,P75),g/d] | BMI [M(P25,P75),kg/m2] | |||||||
| 经常饮酒 | 偶尔饮酒 | 已戒酒 | 从不饮酒 | ||||||||
| 健康组 | 6(0.4) | 153(11.1) | 0 | 1 221(88.5) | 0.82(0.77,0.87) | 9.36(7.81,10.87) | 23.62(21.30,25.77) | ||||
| 血脂异常组 | 5(0.8) | 104(15.9) | 0 | 546(83.3) | 0.87(0.83,0.90) | 9.64(7.95,11.13) | 25.24(23.24,28.07) | ||||
| 高血压伴高尿酸组 | 23(4.2) | 95(17.5) | 0 | 425(78.3) | 0.89(0.85,0.93) | 10.02(8.65,11.32) | 26.79(24.31,29.76) | ||||
| 高血糖伴高甘油三酯组 | 2(2.8) | 12(16.7) | 0 | 58(80.5) | 0.93(0.89,0.97) | 8.89(7.57,10.40) | 27.67(23.71,30.10) | ||||
| χ2(H)值 | 65.04 | 514.79a | 36.84a | 337.62a | |||||||
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | |||||||
Table 2 Comparison of baseline characteristics of different potential profile models
| 组别 | 人数 | 性别[名(%)] | 年龄[名(%)] | 吸烟情况[名(%)] | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 男 | 女 | 20~<40岁 | 40~<60岁 | 60~<80岁 | 80~94岁 | 经常吸烟 | 偶尔吸烟 | 已戒烟 | 从不吸烟 | ||
| 健康组 | 1 380 | 843(61.1) | 537(38.9) | 921(66.7) | 304(22.1) | 115(8.3) | 40(2.9) | 189(13.7) | 18(1.3) | 5(0.3) | 1 168(84.6) |
| 血脂异常组 | 655 | 478(73.0) | 177(27.0) | 347(53.0) | 202(30.8) | 78(11.9) | 28(4.3) | 118(18.0) | 8(1.2) | 3(0.5) | 526(80.3) |
| 高血压伴高尿酸组 | 543 | 460(84.7) | 83(15.3) | 277(51.0) | 170(31.3) | 74(13.6) | 22(4.0) | 133(24.5) | 15(2.8) | 12(2.2) | 383(70.5) |
| 高血糖伴高甘油三酯组 | 72 | 55(76.4) | 17(23.6) | 17(23.6) | 26(36.1) | 23(32.0) | 6(8.3) | 22(30.6) | 0 | 0 | 50(69.4) |
| χ2(H)值 | 110.23 | 110.74 | 200.99 | ||||||||
| P值 | <0.001 | <0.001 | <0.001 | ||||||||
| 组别 | 饮酒情况[名(%)] | WH R [M(P25,P75)] | DSI [M(P25,P75),g/d] | BMI [M(P25,P75),kg/m2] | |||||||
| 经常饮酒 | 偶尔饮酒 | 已戒酒 | 从不饮酒 | ||||||||
| 健康组 | 6(0.4) | 153(11.1) | 0 | 1 221(88.5) | 0.82(0.77,0.87) | 9.36(7.81,10.87) | 23.62(21.30,25.77) | ||||
| 血脂异常组 | 5(0.8) | 104(15.9) | 0 | 546(83.3) | 0.87(0.83,0.90) | 9.64(7.95,11.13) | 25.24(23.24,28.07) | ||||
| 高血压伴高尿酸组 | 23(4.2) | 95(17.5) | 0 | 425(78.3) | 0.89(0.85,0.93) | 10.02(8.65,11.32) | 26.79(24.31,29.76) | ||||
| 高血糖伴高甘油三酯组 | 2(2.8) | 12(16.7) | 0 | 58(80.5) | 0.93(0.89,0.97) | 8.89(7.57,10.40) | 27.67(23.71,30.10) | ||||
| χ2(H)值 | 65.04 | 514.79a | 36.84a | 337.62a | |||||||
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | |||||||
| 分组 | 模型1 | 模型2 | 模型3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| B值 | OR(95%CI) | P值 | B值 | OR(95%CI) | P值 | B值 | OR(95%CI) | P值 | |
| 血脂异常组 | -0.111 | 0.895(0.839~0.953) | 0.001 | -0.115 | 0.892(0.836~0.950) | <0.001 | -0.123 | 0.884(0.824~0.949) | 0.001 |
| 高血压伴高尿酸组 | -0.096 | 0.908(0.847~0.975) | 0.008 | -0.094 | 0.910(0.848~0.978) | 0.010 | -0.101 | 0.904(0.832~0.982) | 0.017 |
| 高血糖伴高甘油三酯组 | -0.277 | 0.758(0.642~0.895) | 0.001 | -0.277 | 0.758(0.642~0.895) | 0.001 | -0.529 | 0.589(0.417~0.832) | 0.003 |
Table 3 Multicategorical Logistic regression analysis of the potential profile model classification of cardiovascular metabolic risk by DSI
| 分组 | 模型1 | 模型2 | 模型3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| B值 | OR(95%CI) | P值 | B值 | OR(95%CI) | P值 | B值 | OR(95%CI) | P值 | |
| 血脂异常组 | -0.111 | 0.895(0.839~0.953) | 0.001 | -0.115 | 0.892(0.836~0.950) | <0.001 | -0.123 | 0.884(0.824~0.949) | 0.001 |
| 高血压伴高尿酸组 | -0.096 | 0.908(0.847~0.975) | 0.008 | -0.094 | 0.910(0.848~0.978) | 0.010 | -0.101 | 0.904(0.832~0.982) | 0.017 |
| 高血糖伴高甘油三酯组 | -0.277 | 0.758(0.642~0.895) | 0.001 | -0.277 | 0.758(0.642~0.895) | 0.001 | -0.529 | 0.589(0.417~0.832) | 0.003 |
| 分组 | 交互项 | B | SE | Wald χ2值 | P值 | OR(95%CI) |
|---|---|---|---|---|---|---|
| 血脂异常组 | DSI×性别 | 0.413 | 0.146 | 7.945 | 0.005 | 1.511(1.134~2.013) |
| DSI×(40~<60岁) | -0.326 | 0.132 | 6.139 | 0.013 | 0.722(0.558~0.934) | |
| DSI×(60~<80岁) | -0.598 | 0.198 | 9.123 | 0.003 | 0.550(0.373~0.811) | |
| DSI×(80~94岁) | -0.001 | 0.363 | 0.000 | 0.998 | 0.999(0.491~2.035) | |
| DSI×BMI | 0.099 | 0.054 | 3.363 | 0.067 | 1.104(0.993~1.228) | |
| DSI×WH R | 0.154 | 0.060 | 6.587 | 0.010 | 1.167(1.037~1.312) | |
| 高血压伴高尿酸组 | DSI×性别 | 0.289 | 0.180 | 2.570 | 0.109 | 1.335(0.938~1.900) |
| DSI×(40~<60岁) | -0.323 | 0.156 | 4.288 | 0.038 | 0.724(0.534~0.983) | |
| DSI×(60~<80岁) | -0.252 | 0.209 | 1.445 | 0.229 | 0.777(0.516~1.172) | |
| DSI×(80~94岁) | -0.210 | 0.404 | 0.269 | 0.604 | 0.811(0.368~1.789) | |
| DSI×BMI | -0.013 | 0.064 | 0.040 | 0.842 | 0.987(0.871~1.119) | |
| DSI×WH R | 0.007 | 0.077 | 0.009 | 0.924 | 1.007(0.867~1.170) | |
| 高血糖伴高甘油三酯组 | DSI×性别 | -0.390 | 0.350 | 1.245 | 0.265 | 0.677(0.341~1.343) |
| DSI×(40~<60岁) | -0.050 | 0.408 | 0.015 | 0.903 | 0.952(0.428~2.116) | |
| DSI×(60~<80岁) | 0.211 | 0.428 | 0.243 | 0.622 | 1.235(0.534~2.855) | |
| DSI×(80~94岁) | -0.628 | 0.700 | 0.804 | 0.370 | 0.534(0.135~2.105) | |
| DSI×BMI | 0.227 | 0.113 | 4.025 | 0.045 | 1.255(1.005~1.568) | |
| DSI×WH R | 0.292 | 0.158 | 3.431 | 0.064 | 1.339(0.983~1.824) |
Table 4 Analysis of the impact of the interaction between DSI and other factors on cardiovascular metabolic risk stratification
| 分组 | 交互项 | B | SE | Wald χ2值 | P值 | OR(95%CI) |
|---|---|---|---|---|---|---|
| 血脂异常组 | DSI×性别 | 0.413 | 0.146 | 7.945 | 0.005 | 1.511(1.134~2.013) |
| DSI×(40~<60岁) | -0.326 | 0.132 | 6.139 | 0.013 | 0.722(0.558~0.934) | |
| DSI×(60~<80岁) | -0.598 | 0.198 | 9.123 | 0.003 | 0.550(0.373~0.811) | |
| DSI×(80~94岁) | -0.001 | 0.363 | 0.000 | 0.998 | 0.999(0.491~2.035) | |
| DSI×BMI | 0.099 | 0.054 | 3.363 | 0.067 | 1.104(0.993~1.228) | |
| DSI×WH R | 0.154 | 0.060 | 6.587 | 0.010 | 1.167(1.037~1.312) | |
| 高血压伴高尿酸组 | DSI×性别 | 0.289 | 0.180 | 2.570 | 0.109 | 1.335(0.938~1.900) |
| DSI×(40~<60岁) | -0.323 | 0.156 | 4.288 | 0.038 | 0.724(0.534~0.983) | |
| DSI×(60~<80岁) | -0.252 | 0.209 | 1.445 | 0.229 | 0.777(0.516~1.172) | |
| DSI×(80~94岁) | -0.210 | 0.404 | 0.269 | 0.604 | 0.811(0.368~1.789) | |
| DSI×BMI | -0.013 | 0.064 | 0.040 | 0.842 | 0.987(0.871~1.119) | |
| DSI×WH R | 0.007 | 0.077 | 0.009 | 0.924 | 1.007(0.867~1.170) | |
| 高血糖伴高甘油三酯组 | DSI×性别 | -0.390 | 0.350 | 1.245 | 0.265 | 0.677(0.341~1.343) |
| DSI×(40~<60岁) | -0.050 | 0.408 | 0.015 | 0.903 | 0.952(0.428~2.116) | |
| DSI×(60~<80岁) | 0.211 | 0.428 | 0.243 | 0.622 | 1.235(0.534~2.855) | |
| DSI×(80~94岁) | -0.628 | 0.700 | 0.804 | 0.370 | 0.534(0.135~2.105) | |
| DSI×BMI | 0.227 | 0.113 | 4.025 | 0.045 | 1.255(1.005~1.568) | |
| DSI×WH R | 0.292 | 0.158 | 3.431 | 0.064 | 1.339(0.983~1.824) |
| 变量 | 模型1 | 模型2 | 模型3 | |||
|---|---|---|---|---|---|---|
| β值(95%CI) | P值 | β值(95%CI) | P值 | β值(95%CI) | P值 | |
| 常量 | -3.844(-4.18~-3.505) | <0.001 | -25.365(-27.336~-23.394) | <0.001 | -26.448(-28.968~-23.927) | <0.001 |
| 性别(以女为参照) | ||||||
| 男 | 4.236(3.888~4.583) | <0.001 | 1.911(1.486~2.335) | <0.001 | 1.955(1.477~2.433) | <0.001 |
| 年龄(以20~<40岁为参照) | ||||||
| 40~<60岁 | 2.043(1.673~2.414) | <0.001 | 1.029(0.689~1.369) | <0.001 | 1.003(0.660~1.347) | <0.001 |
| 60~<80岁 | 2.772(2.251~3.294) | <0.001 | 0.679(0.163~1.196) | 0.010 | 0.357(-0.225~0.939) | 0.230 |
| 80~94岁 | 1.795(0.949~2.640) | <0.001 | 0.366(-0.427~1.159) | 0.366 | -0.018(-1.266~1.231) | 0.978 |
| BMI | 0.308(0.263~0.353) | <0.001 | 0.317(0.272~0.363) | <0.001 | ||
| WH R | 20.777(17.683~23.872) | <0.001 | 20.555(17.454~23.656) | <0.001 | ||
| 吸烟情况(以否为参照) | ||||||
| 经常吸烟 | 0.107(-0.297~0.510) | 0.605 | 0.131(-0.321~0.582) | 0.571 | ||
| 偶尔吸烟 | -0.050(-1.159~1.060) | 0.930 | -0.449(-1.732~0.835) | 0.493 | ||
| 已戒烟 | 0.428(-1.129~1.984) | 0.590 | 0.575(-1.02~2.171) | 0.480 | ||
| 饮酒情况(以否为参照) | ||||||
| 经常饮酒 | 1.890(0.685~3.096) | 0.002 | 2.065(0.713~3.417) | 0.003 | ||
| 偶尔饮酒 | 0.133(-0.293~0.56) | 0.540 | 0.298(-0.209~0.805) | 0.249 | ||
| DSI | -0.180(-0.262~-0.097) | <0.001 | -0.081(-0.283~0.122) | 0.434 | ||
| DSI×男 | 0.058(-0.407~0.523) | 0.806 | ||||
| DSI×(40~<60岁) | -0.576(-0.947~-0.204) | 0.002 | ||||
| DSI×(60~<80岁) | -0.891(-1.472~-0.310) | 0.003 | ||||
| DSI×(80~94岁) | -0.78(-1.812~0.252) | 0.138 | ||||
| DSI×BMI | -0.12(-0.302~0.061) | 0.194 | ||||
| DSI×WH R | 0.053(-0.17~0.276) | 0.641 | ||||
| DSI×经常吸烟 | -0.091(-0.598~0.416) | 0.725 | ||||
| DSI×偶尔吸烟 | 0.833(-0.698~2.365) | 0.286 | ||||
| DSI×已戒烟 | -0.129(-3.091~2.834) | 0.932 | ||||
| DSI×经常饮酒 | -0.183(-1.997~1.631) | 0.843 | ||||
| DSI×偶尔饮酒 | -0.337(-0.886~0.212) | 0.229 | ||||
| R2 | 0.194 | 0.409 | 0.414 | |||
| ∆R2 | 0.194 | 0.214 | 0.005 | |||
| F值 | 159.603 | <0.001 | 151.951 | <0.001 | 80.624 | 0.019 |
Table 5 Hierarchical regression analysis of the composite score for cardiovascular metabolic risk
| 变量 | 模型1 | 模型2 | 模型3 | |||
|---|---|---|---|---|---|---|
| β值(95%CI) | P值 | β值(95%CI) | P值 | β值(95%CI) | P值 | |
| 常量 | -3.844(-4.18~-3.505) | <0.001 | -25.365(-27.336~-23.394) | <0.001 | -26.448(-28.968~-23.927) | <0.001 |
| 性别(以女为参照) | ||||||
| 男 | 4.236(3.888~4.583) | <0.001 | 1.911(1.486~2.335) | <0.001 | 1.955(1.477~2.433) | <0.001 |
| 年龄(以20~<40岁为参照) | ||||||
| 40~<60岁 | 2.043(1.673~2.414) | <0.001 | 1.029(0.689~1.369) | <0.001 | 1.003(0.660~1.347) | <0.001 |
| 60~<80岁 | 2.772(2.251~3.294) | <0.001 | 0.679(0.163~1.196) | 0.010 | 0.357(-0.225~0.939) | 0.230 |
| 80~94岁 | 1.795(0.949~2.640) | <0.001 | 0.366(-0.427~1.159) | 0.366 | -0.018(-1.266~1.231) | 0.978 |
| BMI | 0.308(0.263~0.353) | <0.001 | 0.317(0.272~0.363) | <0.001 | ||
| WH R | 20.777(17.683~23.872) | <0.001 | 20.555(17.454~23.656) | <0.001 | ||
| 吸烟情况(以否为参照) | ||||||
| 经常吸烟 | 0.107(-0.297~0.510) | 0.605 | 0.131(-0.321~0.582) | 0.571 | ||
| 偶尔吸烟 | -0.050(-1.159~1.060) | 0.930 | -0.449(-1.732~0.835) | 0.493 | ||
| 已戒烟 | 0.428(-1.129~1.984) | 0.590 | 0.575(-1.02~2.171) | 0.480 | ||
| 饮酒情况(以否为参照) | ||||||
| 经常饮酒 | 1.890(0.685~3.096) | 0.002 | 2.065(0.713~3.417) | 0.003 | ||
| 偶尔饮酒 | 0.133(-0.293~0.56) | 0.540 | 0.298(-0.209~0.805) | 0.249 | ||
| DSI | -0.180(-0.262~-0.097) | <0.001 | -0.081(-0.283~0.122) | 0.434 | ||
| DSI×男 | 0.058(-0.407~0.523) | 0.806 | ||||
| DSI×(40~<60岁) | -0.576(-0.947~-0.204) | 0.002 | ||||
| DSI×(60~<80岁) | -0.891(-1.472~-0.310) | 0.003 | ||||
| DSI×(80~94岁) | -0.78(-1.812~0.252) | 0.138 | ||||
| DSI×BMI | -0.12(-0.302~0.061) | 0.194 | ||||
| DSI×WH R | 0.053(-0.17~0.276) | 0.641 | ||||
| DSI×经常吸烟 | -0.091(-0.598~0.416) | 0.725 | ||||
| DSI×偶尔吸烟 | 0.833(-0.698~2.365) | 0.286 | ||||
| DSI×已戒烟 | -0.129(-3.091~2.834) | 0.932 | ||||
| DSI×经常饮酒 | -0.183(-1.997~1.631) | 0.843 | ||||
| DSI×偶尔饮酒 | -0.337(-0.886~0.212) | 0.229 | ||||
| R2 | 0.194 | 0.409 | 0.414 | |||
| ∆R2 | 0.194 | 0.214 | 0.005 | |||
| F值 | 159.603 | <0.001 | 151.951 | <0.001 | 80.624 | 0.019 |
| [1] |
国家心血管病中心,中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2023概要[J]. 中国循环杂志, 2024, 39(7): 625-660.
|
| [2] |
郑东东,段盈竹,于睿. 1990—2021年中国心血管疾病负担变化趋势、可改善危险因素和疾病负担的预测[J]. 中国循环杂志, 2025, 40(5): 501-507.
|
| [3] |
|
| [4] |
|
| [5] |
郭丹,丁若溪,何平. 中国老年人心血管代谢性共病的患病情况及影响因素研究[J]. 中国慢性病预防与控制, 2023, 31(2): 101-105.
|
| [6] |
|
| [7] |
World Health Organization. Guideline: sodium intake for adults and children[R]. 2012.
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
王莉,奚雪梅,谢英柱,等. 原发性高血压患者摄盐量与冠脉病变程度的相关性研究[J]. 航空航天医学杂志, 2025, 36(9): 1028-1031.
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
罗玉霜. 盐摄入量与肥胖及心血管疾病风险关系的研究[D]. 重庆: 西南大学, 2025.
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
张馨予. 盐敏感高血压干预新靶标的探索性研究[D]. 北京: 北京协和医学院, 2013.
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [1] | ZENG Qingqiu, WANG Hongyi, YE Jingxue, LIU Dan, JIANG Lihua. Latent Profiles and Influencing Factors of Structured Competencies among Members of Public Health Committees under Village (Neighborhood) Committees in Chengdu [J]. Chinese General Practice, 2026, 29(35): 5197-5202. |
| [2] | ZHANG Ying, TANG Yijun, LIU Lidi, JIANG Lihua, JIA Yu, YANG Rong, YANG Ziyu, LIAO Xiaoyang. Management of Cardiovascular Metabolic Risks in Obese Children and Adolescents in China: Based on the 2024 Italian Society of Pediatric Endocrinology and Diabetes Position Paper on Cardiometabolic Risk in Children and Adolescents with Obesity [J]. Chinese General Practice, 2026, 29(27): 3879-3887. |
| [3] | ZHANG Boyu, XU Bo, LI Jianguo, YIN He, LUO Pengren, WANG Haojie, JIN Zhefeng, ZHU Liguo. Research on the Diagnostic Value of Rasterstereography for Angles Related to Adolescent Idiopathic Scoliosis [J]. Chinese General Practice, 2026, 29(24): 3434-3439. |
| [4] | NI Yidan, WANG Ying, ZHU Yuke, XU Jing, WANG Li. The Latent Profile Analysis of Functional Fitness and Influencing Factors in Community-dwelling Older Adults [J]. Chinese General Practice, 2026, 29(24): 3493-3499. |
| [5] | NIE Jiahui, LI Guojuan, HAO Zhuoqun, DU Qiaorong, LIU Penghong, LIU Zhifen, LIU Sha, ZHANG Aixia, WANG Yanfang. Heterogeneity and Influencing Factors of Cognitive Function Impairment in Patients with Major Depressive Disorder [J]. Chinese General Practice, 2026, 29(17): 2340-2346. |
| [6] | CHEN Jiali, ZHANG Jingjing, WANG Hexia, TANG Xiaorui, WU Yujie, LEI Yang, LIN Zheng. Latent Profile Analysis of Chronic Illness Resource Utilization and Its Impact on Health-promoting Behaviors in Individuals with Prediabetes [J]. Chinese General Practice, 2026, 29(16): 2244-2251. |
| [7] | SUN Qinyu, DENG Yifan, YANG Tianxiao, FANG Zhen, JI Jun, HE Shenghu, ZHANG Jing. Clinical Study of HbA1c/ApoA-1, TyG-BMI and Their Combination to Predict the Severity of Coronary Artery Calcification [J]. Chinese General Practice, 2026, 29(09): 1137-1145. |
| [8] | SHENG Luguang, LIU Dandan, LIU Weibin, LU Jun, LEI Tao, CHEN Qingguang, LU Hao, XU Bilin. Effects of Short-term Dietary Intervention for Obese Patients with Abnormal Glucose Metabolism [J]. Chinese General Practice, 2026, 29(03): 373-379. |
| [9] | ZHOU Qianmei, MIAO Kali, ZHONG Yongming, ZHANG Fuman, ZHANG Zhe, LI Chengyi. Gas6 Expression in Breast Cancer and Correlation with Clinical Pathological Features and Prognosis [J]. Chinese General Practice, 2025, 28(35): 4449-4456. |
| [10] | CHEN Huiyu, XU Ziyan, LI Yuhong. Correlation between Dietary Inflammatory Index and Delayed Onset of Lactogenesis in Women of the Third Trimester [J]. Chinese General Practice, 2025, 28(35): 4442-4448. |
| [11] | WANG Biyou, GAO Ying, YOU Junfang, LIU Li, ZHANG Qing, SU Haiyan. Canonical Correlation Analysis of Lipid Ratios and Inflammatory Markers in Individuals at Risk of Cardiovascular Disease [J]. Chinese General Practice, 2025, 28(33): 4132-4139. |
| [12] | HAN Bing, DU Shuzhen, MENG Xiaoxue, ZHANG Lu, CHEN Zixian, TENG Fengling. Plasma Periostin Levels Correlated with Myocardial Fibrosis in Patients with Heart Failure with Different Ejection Fraction [J]. Chinese General Practice, 2025, 28(24): 2979-2984. |
| [13] | YOU Zhanhong, SUN Guozhen, LU Jing, TANG Zhijie, WANG Jie, WANG Qin, WANG Lin. Latent Profile Analysis and Its Influencing Factors of Physical Activity in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(12): 1486-1493. |
| [14] | ZHANG Minrui, LI Dan, HE Meihui, GAO Ruixiang. Do Higher Intellectuals Trust Traditional Chinese Medicine More? [J]. Chinese General Practice, 2025, 28(09): 1044-1051. |
| [15] | CHENG Lu, QIN Cun, BAI Pinqing, WANG Jianying, REN Yaping, HU Xiaojuan, ZHANG Baojun, ZHANG Lei, ZHOU Yixin. Correlation between Traditional Chinese Medicine Constitution and Blood Lipid Metabolism in Children: Based on the Shanghai Child and Adolescent Health Cohort [J]. Chinese General Practice, 2025, 28(06): 751-755. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||